In a recent press release, Santen announced that the FDA approved OMLONTI, the company’s newest ophthalmic medication. This ophthalmic solution is composed of 0.002% omidenepag isopropyl. This...
Many vitamins and supplements are readily available over the counter for patient use. Understanding the effects of supplements on healthcare can impact and inform physician practices for more effective...
As new COVID boosters are approved and distributed, understanding how they affect pregnant and lactating individuals will impact public health policies, educational efforts, and provider distribution....
Earlier this week, the FDA and NIH announced their launch of a public–private partnership for research on rare neurodegenerative diseases. The partnership, called the Critical Path for Rare...
Results from the Phase III CodeBreaK 200 clinical trial found that Amgen’s targeted therapy Lumakras successfully extended progression-free survival (PFS) by about two months and was 15% more...
The Advanced Research Projects Agency for Health (ARPA-H) was proposed by the Biden Administration on March 15, 2022, as a government organization to drive biomedical and healthcare innovation. Under...
Glucocorticoids are widely prescribed for those struggling with autoimmune and neurological conditions and are considered one of the most prescribed drugs. In a study published in BMJ Open, researchers...
A study published on September 1st in the New England Journal of Medicine tracking health data from 109,254 Israeli adults found a 73% reduction in hospitalization and a 79% reduction in COVID-19...
Wearable devices have gained much traction recently for their potential uses in the healthcare industry. Recently, Northwestern University has collaborated with Johns Hopkins University on a research...
While the general public may feel we are post-pandemic, healthcare workers know that COVID still runs rampant worldwide, especially in hospital settings. The recent study published in JAMA Network Open...
A recent study in JAMA Open Network looked at the relationship between fluoroquinolone — an antibiotic — dosage and adverse side effects in patients with CKD. The researchers found that...
A cohort study in JAMA Network Open analyzed the efficacy of the COVID-19 vaccine in preventing SARS-CoV-2 reinfection. The study found that COVID-19 vaccination reduced reinfection rates by...
According to a recent press release, Astellas and Seagen have teamed up to develop a combined treatment for urothelial cancer in patients who are ineligible to receive cisplatin chemotherapy. The new...
The Kaiser Family Foundation (KFF) recently found that pediatric COVID-19 vaccination rates in children under 5 years old have decreased despite the age bracket’s very recent eligibility....
Abbott recently announced that they had been granted Breakthrough Device Designation by the FDA, which allows them to investigate the use of deep brain stimulation (DBS) in managing severe...
A recent statement by Verve Therapeutics announced the start of the phase 1b clinical trial on heterozygous familial hypercholesterolemia (HeFH) in New Zealand. This announcement highlighted the first...
According to a cross-sectional survey study published in JAMA, remote and decentralization tools can improve clinical trial enrollment and participation in cancer studies.
Recently, many...
At the end of June, Decibel Therapeutics announced success in the phase 1b clinical trials on DB-020 for cancer patients receiving cisplatin chemotherapy. DB-020 is a sodium thiosulfate (STS) drug...
Recently, the FDA approved a new second-line treatment for large B-cell lymphoma (LBCL). Lisocabtagene maraleucel is the generic name for Breyanzi, developed and marketed by Juno Therapeutics. As a...
Recently, the FDA approved Qsymia for chronic weight management in pediatric patients over 12 years old. Qsymia is an extended-release pill composed of phentermine and topiramate. The drug’s...
